Aqemia
FranceWho owns Aqemia?
Aqemia is a French Biotech company, currently owned by Cathay Capital since 2024 and 4 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Elaia Partners, Lazard Elaia Capital, Eurazeo, Wendel and Cathay Capital since 2019.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Cathay Innovation Fund III
Other portfolio companies in the same fund.
US
SpainMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Aqemia?
Aqemia is currently owned by Cathay Capital, Wendel and 3 others, through Cathay Innovation Fund III, since 2024.
When did Cathay Capital and 4 others acquire Aqemia?
Cathay Capital and 4 others acquired Aqemia in 2024.
Who has owned Aqemia over time?
Aqemia has been through 5 private-equity ownership periods: Elaia Partners · via PSL Innovation Fund · since 2019; Lazard Elaia Capital · via Elaia Legacy Fund · since 2020; Eurazeo · via Idinvest Digital Fund III · since 2020; Wendel · via Wendel Growth · since 2023; Cathay Capital · via Cathay Innovation Fund III · since 2024.